MAM
LXRX icon

Monaco Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Monaco Asset Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-117,188
Closed -$135K – 89
2025
Q4 		$135K Sell
117,188
-232,812
-67% -$320K 0.02% 79
2025
Q3 		$473K Sell
350,000
-181,600
-34% -$206K 0.03% 82
2025
Q2 		$503K Sell
531,600
-202,548
-28% -$131K 0.09% 84
2025
Q1 		$338K Buy
+734,148
New +$463K 0.07% 67

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Monaco Asset Management's LXRX Position: Q1 2026 in Review

Monaco Asset Management sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2026, closing a stake of 117,188 shares — an estimated $135K sold.

Monaco Asset Management first reported a position in LXRX in Q1 2025 and held it in 4 quarters. The position peaked at $503K in Q2 2025. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • Monaco Asset Management reported no remaining Lexicon Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Monaco Asset Management sold 117,188 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $135K.
  • Monaco Asset Management first reported a position in Lexicon Pharmaceuticals in Q1 2025 and held it in 4 quarters.
  • Monaco Asset Management's Lexicon Pharmaceuticals position peaked at $503K in Q2 2025.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Monaco Asset Management's 13F filing for Q1 2026, filed 11 May 2026.